Publications — Group A streptococcus
Return to Publications Menu
2006 to present:
O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, and Van Beneden C for the Active Bacterial Core Surveillance Team. The Epidemiology of Invasive Group A Streptococcal Infection and Potential Vaccine Implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853-61.
Thigpen MC, Richards CL, Lynfield R, Barrett NL, Harrison LH, Arnold KE, Reingold A, Bennett NM, Craig AS, Gershman K, Cieslak PR, Lewis P, Greene CM, Beall B, and Van Beneden CA for the Active Bacterial Core Surveillance/Emerging Infections Program Network. Invasive Group A Streptococcal Infection in Older Adults in Long-term Care Facilities and the Community, United States, 1998-2003. Emerging Infectious Diseases 2007;13:1852-59.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2006. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas06.pdf
Johnson DR , Kaplan EL, VanGheem A, Facklam RR, Beall B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol. 2006;55:157-64.
Persson J, Beall B, Linse S, Lindhal G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog 2006; 2(5):e47. Epub 2006 May 26.
Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, Klugman KP. The emergence of fluoroquinolone-resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother. 2006;50:943-8.
Sakota V, Fry AM, Lietman TM, Facklam RR, Li Z, Beall B. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol. 2006;44(6):2160-6.
Back to Top
2000-2005:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2005. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas05.pdf
Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol. 2005;12:833-6.
Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, Wright T, Schwartz B, Schuchat A. Risk Factors for Pediatric Invasive Group A Streptococcal Disease. Emerg Infect Dis 2005;11(7):1062-6.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2004. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas04.pdf
Shulman ST, Tanz RR, Kabat K, Cederlund E, Patel D, Li Z, Sakota V, Dale JB, Beall B. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis 2004;39:325-32.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2003. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas03.pdf
Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M-protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J. Clin Microbiol 2003;41:373-8.
Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003;9(8): 970-7.
Igwe EI, Shewmaker PL, Facklam RR, Farley MM, Van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 2003;229(2):259-64.
Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol 2003;185(4):1208-17.
Li Z, Sakota V, Jackson D, Franklin AR, Beall B; Active Bacterial Core Surveillance/Emerging Infections Program Network. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis 2003;188(10):1587-92.
Passaro DJ, Smith DS, Hett EC, Reingold AL, Daily P, Van Beneden CA , Vugia DJ. Invasive Group A Streptococcal Infections in the San Francisco Bay Area, 1989-1999. Epidemiol Infect 2003;129(3): 471-8.
Robinson KA. Rothrock G. Phan Q. Sayler B. Stefonek K. Van Beneden C. Levine OS. Active Bacterial Core Surveillance/Emerging Infections Program Network. Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis 2003;9(4):443-7.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2002. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas02.pdf
Chuang I, Van Beneden C, Beall B, Schuchat A and the ABCs/EIP Network. Population-based surveillance for postpartum invasive group A streptococcal infections, 1995-2000. Clin Infect Dis 2002;35:665-70.
Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J Clin Microbiol 2002;41:373-8.
Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstraiou A, Thompson TA, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, and Beall B. Extension of the classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm104. Clin Infect Dis 2002;34:28-38.
Hu MC, Walls MA, Stroop S, Reddish M, Beall B, and Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002;70:2171-77.
O'Brien K, Beall B, Barrett NL, Cieslak, Ringold A, Farley MM, Danila, Zell ER, Facklam R, Schwartz B, Schuchat A. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002;35:268-76.
The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case-patients and among postpartum and post-surgical patients: Recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002;35:950-9.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2001. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas01_provis.pdf
Stefonek KR, Maerz LL, Nielson MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol 2001;98:846-48.
Beall B, Gherardi G, Lovgren M, Forwick B, Facklam R, and Tyrrell G. emm and sof gene sequence variation in relation to serological typing of opacity factor positive group A streptococci. Microbiol 2000;146:1195-1209.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2000. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas00.pdf
Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, De Azavedo JC. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun 2000;68(7):4245-54.
Back to Top
1995-1999:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1999. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas99.pdf
Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, Kriz P, Lovgren M, Martin D, Schwartz B, Totolian A, Bessen D, Hollingshead S, Rubin F, Scott J, Tyrrell, G. Demonstration of emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999;5:247-53.
Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmenlinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, DeLorenzo D Yun-Xin F, Musser JM. Rapid selection of structural variants of group A streptococcus complement-inhibiting protein sustains and enlarges serotype M1 epidemic waves. Nat Med 1999;5:924-9.
York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J Clin Microbiol 1999;37(6):1727-31.
Beall B, Facklam R, Elliott JA, Franklin AR, Hoenes T, Jackson D, Laclaire L, Thompson T, Viswanathan R. Streptococcal emm types associated with T agglutination patterns and the use of conserved emm gene restriction fragment patterns for sub-typing group A streptococci. J Med Microbiol 1998;47:893-8.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1998. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas98.pdf
The Working Group on Prevention of Invasive Group A Streptococcal Infections. Prevention of invasive group A streptococcal disease among household contacts of case-patients. JAMA 1998;279:1206-10.
Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam RR, Schwartz B, Farley M. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998;27:150-7.
Beall B, Facklam R, Hoenes T, Schwartz B. A survey of emm gene sequences from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol 1997;35:1231-5.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1997. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas97.pdf
Fiorentino TR,Beall B, Mshar P, Bessen DE. A genetic-based evaluation of principal tissue reservoir for group A streptococci isolated from normally sterile sites. J Infect Dis 1997;176:177-82.
Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996;34:953-58.
Back to Top
|
